Does Rallies show Form 4 insider transactions for STTK?

Yes. Rallies tracks STTK insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is STTK research on Rallies investment advice?

No. Rallies provides research, data, and educational context for STTK. It does not provide personalized investment advice.

STTK (Shattuck Labs, Inc. Common Stock) Stock Analysis - Insider Trades

Shattuck Labs, Inc. Common Stock (STTK) is a publicly traded Healthcare sector company. As of May 21, 2026, STTK trades at $6.29 with a market cap of $457.78M and a P/E ratio of -10.20. STTK moved +6.82% today. Year to date, STTK is +58.61%; over the trailing twelve months it is +499.03%. Its 52-week range spans $0.69 to $8.33. Analyst consensus is strong buy with an average price target of $13.00. Rallies surfaces STTK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading STTK stock inside the company?

Recent STTK insider activity includes Shukla Abhinav A. sold 2.03K, Pandite Arundathy N. sold 30.00K, ORBIMED ADVISORS LLC bought 5.26M, ORBIMED ADVISORS LLC bought 1.05M, and Ashiya Mona bought 5.26M. Rallies tracks insider transaction dates, shares, prices, and estimated values.

STTK Key Metrics

Key financial metrics for STTK
Metric	Value
Price	$6.29
Market Cap	$457.78M
P/E Ratio	-10.20
EPS	$-0.59
Dividend Yield	0.00%
52-Week High	$8.33
52-Week Low	$0.69
Volume	279.60K
Avg Volume	0
Revenue (TTM)	$1.00M
Net Income	$-49.87M
Gross Margin	0.00%

Recent STTK Insider Trades

Shukla Abhinav A. sold 2.03K (~$14.24K) on May 12, 2026.
Pandite Arundathy N. sold 30.00K (~$198.30K) on May 12, 2026.
ORBIMED ADVISORS LLC bought 5.26M (~$4.56M) on Aug 25, 2025.
ORBIMED ADVISORS LLC bought 1.05M (~$911.97K) on Aug 25, 2025.
Ashiya Mona bought 5.26M (~$4.56M) on Aug 25, 2025.

Latest STTK News

Shattuck Labs Completes Phase 1 Enrollment, Q1 Cash Grows to $90.4 Million — May 7, 2026

STTK Analyst Consensus

7 analysts cover STTK: 0 strong buy, 6 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $13.00.

Common questions about STTK

Who is trading STTK stock inside the company?: Recent STTK insider activity includes Shukla Abhinav A. sold 2.03K, Pandite Arundathy N. sold 30.00K, ORBIMED ADVISORS LLC bought 5.26M, ORBIMED ADVISORS LLC bought 1.05M, and Ashiya Mona bought 5.26M. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for STTK?: Yes. Rallies tracks STTK insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is STTK research on Rallies investment advice?: No. Rallies provides research, data, and educational context for STTK. It does not provide personalized investment advice.